Your browser doesn't support javascript.
loading
Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo.
Martomo, Stella A; Patel, Jeegar.
Affiliation
  • Martomo SA; Kadmon Corporation, a Sanofi Company, 450 East 29th Street, New York, NY, 10016, USA. stellamartomo@gmail.com.
  • Patel J; Kadmon Corporation, a Sanofi Company, 450 East 29th Street, New York, NY, 10016, USA.
Cancer Immunol Immunother ; 72(6): 1941-1950, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36454338
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: